Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases

International Journal of Antimicrobial Agents

Volumn 42, Issue 4, 2013, Pages 347-351

  Dahbi, Ghizlane ^a   Mora, Azucena ^a   López, Cecilia ^a   Alonso, María Pilar ^b   Mamani, Rosalía ^a   Marzoa, Juan ^a   Coira, Amparo ^b   García Garrote, Fernando ^b   Pita, Julia María ^b   Velasco, David ^b   Herrera, Alexandra ^a   Viso, Susana ^a   Blanco, Jesús E ^a   Blanco, Miguel ^a   Blanco, Jorge ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b SERGAS   (Spain)

Author keywords

CTX M 15; ESBL; Escherichia coli; ST131

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 27; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; NALIDIXIC ACID; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLONAL SPECIES; CNF1 GENE; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; FIMH GENE; GENE IDENTIFICATION; HLYA GENE; HUMAN; IUCD GENE; KPSM II K5 GENE; MAJOR CLINICAL STUDY; MALX GENE; NONHUMAN; PAPG II GENE; PREVALENCE; PRIORITY JOURNAL; SAT GENE; TRAT GENE; USP GENE;

CTX-M-15; ESBL; ESCHERICHIA COLI; ST131;

BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PROSPECTIVE STUDIES; SEROTYPING; SPAIN; VIRULENCE FACTORS;

EID: 84884703559     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.06.017     Document Type: Article

References (21)

1. N. Woodford, M.E. Ward, M.E. Kaufmann, J. Turton, E.J. Fagan, and D. James Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK J Antimicrob Chemother 54 2004 735 743
2. M.H. Nicolas-Chanoine, J. Blanco, V. Leflon-Guibout, R. Demarty, M.P. Alonso, and M.M. Caniça Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15 J Antimicrob Chemother 61 2008 273 281
3. T.M. Coque, A. Novais, A. Carattoli, L. Poirel, J. Pitout, and L. Peixe Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15 Emerg Infect Dis 14 2008 195 200
4. J.R. Johnson, C. Urban, S.J. Weissman, J.H. Jorgensen, J.S. Lewis 2nd, and G. Hansen Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase- producing E. coli from the United States, 2000 to 2009 Antimicrob Agents Chemother 56 2012 2364 2370
5. A. Mora, M. Blanco, C. López, R. Mamani, J.E. Blanco, and M.P. Alonso Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain Int J Antimicrob Agents 37 2011 16 21
6. J. Blanco, A. Mora, R. Mamani, C. López, M. Blanco, and G. Dahbi National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain J Antimicrob Chemother 66 2011 2011 2021
7. J.L. Platell, R.N. Cobbold, J.R. Johnson, A. Heisig, P. Heisig, and C. Clabots Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia Antimicrob Agents Chemother 55 2011 3782 3787
8. Y. Matsumura, M. Yamamoto, M. Nagao, G. Hotta, A. Matsushima, and Y. Ito Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan J Antimicrob Chemother 67 2012 2612 2620
9. V. Leflon-Guibout, J. Blanco, K. Amaqdouf, K. Amaqdouf, A. Mora, and L. Guize Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France J Clin Microbiol 46 2008 3900 3905
10. M. Blanco, M.P. Alonso, M.H. Nicolas-Chanoine, G. Dahbi, A. Mora, and J.E. Blanco Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15 J Antimicrob Chemother 63 2009 1135 1141
11. J.R. Johnson, M. Menard, B. Johnston, M.A. Kuskowski, K. Nichol, and G.G. Zhanel Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004 Antimicrob Agents Chemother 53 2009 2733 2739
12. J. Oteo, K. Diestra, C. Juan, V. Bautista, A. Novais, and M. Pérez-Vázquez Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2 Int J Antimicrob Agents 34 2009 173 176
13. M.A. Díaz, J.R. Hernández-Bello, J. Rodríguez- Baño, L. Martínez-Martínez, J. Calvo, and J. Blanco Diversity of Escherichia coli strains producing extended-spectrum β-lactamases in Spain: second nationwide study J Clin Microbiol 48 2010 2840 2845
14. A. Coelho, A. Mora, R. Mamani, C. López, J.J. González- López, and M.N. Larrosa Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain) J Antimicrob Chemother 66 2011 517 526
15. L. López-Cerero, M.D. Bellido, L. Serrano, J. Liró, J.M. Cisneros, and J. Rodríguez-Baño Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance Enferm Infecc Microbiol Clin 31 2013 385 388
16. Y. Matsumura, M. Yamamoto, T. Higuchi, T. Komori, F. Tsuboi, and A. Hayashi Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan Int J Antimicrob Agents 40 2012 158 162
17. S. Brisse, L. Diancourt, C. Laouénan, M. Vigan, V. Caro, and G. Arlet Phylogenetic distribution of CTX-M- and non-extended-spectrum-β- lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes J Clin Microbiol 50 2012 2974 2981
18. P.J. Rooney, M.C. O'Leary, A.C. Loughrey, M. McCalmont, B. Smyth, and P. Donaghy Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli J Antimicrob Chemother 64 2009 635 641
19. R. Banerjee, B. Johnston, C. Lohse, S.B. Porter, C. Clabots, and J.R. Johnson Escherichia coli sequence type 131 is a dominant, antimicrobial- resistant clonal group associated with healthcare and elderly hosts Infect Control Hosp Epidemiol 34 2013 361 369
20. J. Oteo, V. Bautista, N. Lara, O. Cuevas, M. Arroyo, and S. Fernández Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli J Antimicrob Chemother 65 2010 2459 2463
21. E. Karisik, M.J. Ellington, D.M. Livermore, and N. Woodford Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum β-lactamases in the UK J Antimicrob Chemother 61 2008 54 58